Cargando…

Effect of Vitamin D(3) Supplementation vs. Dietary–Hygienic Measures on SARS-CoV-2 Infection Rates in Hospital Workers with 25-Hydroxyvitamin D3 [25(OH)D3] Levels ≥20 ng/mL

Background: There is scant information on the effect of supplementation with vitamin D3 in SARS-CoV-2 infection cases when patient 25-hydroxyvitamin D3 [25(OH)D3] levels are between 20–100 ng/mL. We aimed to evaluate the effect of supplementation with vitamin D3 vs. dietary–hygienic measures on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romero-Ibarguengoitia, Maria Elena, Gutiérrez-González, Dalia, Cantú-López, Carlos, Sanz-Sánchez, Miguel Ángel, González-Cantú, Arnulfo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960325/ https://www.ncbi.nlm.nih.gov/pubmed/36838247 http://dx.doi.org/10.3390/microorganisms11020282

Ejemplares similares

Lower placental 25-hydroxyvitamin D(3) (25(OH)D(3)) and higher placental CYP27B1 and 25(OH)D(3) ratio in preterm birth
por: Irwinda, Rima, et al.
Publicado: (2020)

Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased risk of death
por: Smaha, Juraj, et al.
Publicado: (2022)

Serum 25-hydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) concentrations in adult dogs are more substantially increased by oral supplementation of 25-hydroxyvitamin D(3) than by vitamin D(3)
por: Young, Lauren R., et al.
Publicado: (2017)

Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D(3), 1,25-Dihydroxyvitamin D(3) and 24R,25-Dihydroxyvitamin D(3)
por: van der Meijden, Karen, et al.
Publicado: (2014)

25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

25(OH)D status: Effect of D(3) supplement
por: Lukaszuk, J. M., et al.
Publicado: (2017)

Gene-Regulatory Potential of 25-Hydroxyvitamin D(3) and D(2)
por: Hanel, Andrea, et al.
Publicado: (2022)

25-Hydroxyvitamin D(3) and 1,25-Dihydroxyvitamin D(3) Promote the Differentiation of Human Subcutaneous Preadipocytes
por: Nimitphong, Hataikarn, et al.
Publicado: (2012)

Relationship between serum 25 hydroxyvitamin D (25(OH)D) levels and mental health in shift female nurses
por: Tang, Hsin-Ya, et al.
Publicado: (2022)

Association of serum 25-hydroxyvitamin D (25(OH)D) levels with the gut microbiota and metabolites in postmenopausal women in China
por: Gong, Jinhua, et al.
Publicado: (2022)

Association of Dietary Vitamin D Intake, Serum 25(OH)D(3), 25(OH)D(2) with Cognitive Performance in the Elderly
por: Wang, RuTong, et al.
Publicado: (2021)

Vitamin D(3) and 25-hydroxyvitamin D(3) in pork and their relationship to vitamin D status in pigs
por: Burild, Anders, et al.
Publicado: (2016)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

Validation and Determination of 25(OH) Vitamin D and 3-Epi25(OH)D3 in Breastmilk and Maternal- and Infant Plasma during Breastfeeding
por: Gjerde, Jennifer, et al.
Publicado: (2020)

The Association of 25-Hydroxyvitamin D(3) and D(2) with Behavioural Problems in Childhood
por: Tolppanen, Anna-Maija, et al.
Publicado: (2012)

Assessment of Vitamin D Status in Slovenian Premenopausal and Postmenopausal Women, Using Total, Free, and Bioavailable 25-Hydroxyvitamin D (25(OH)D)
por: Vičič, Vid, et al.
Publicado: (2022)

Differential Effects of 25-Hydroxyvitamin D(3) versus 1α 25-Dihydroxyvitamin D(3) on Adipose Tissue Browning in CKD-Associated Cachexia
por: Mak, Robert H., et al.
Publicado: (2021)

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Treatment of an Intramammary Bacterial Infection with 25-Hydroxyvitamin D(3)
por: Lippolis, John D., et al.
Publicado: (2011)

Role of 25-Hydroxyvitamin D(3) and 1,25-Dihydroxyvitamin D(3) in Chicken Embryo Osteogenesis, Adipogenesis, Myogenesis, and Vitamin D(3) Metabolism
por: Chen, Chongxiao, et al.
Publicado: (2021)

Discrepant association of serum C-3 epimer of 25-hydroxyvitamin D versus non-epimeric 25-hydroxyvitamin D with serum lipid levels
por: Chailurkit, La-or, et al.
Publicado: (2016)

Metabolic Advantage of 25(OH)D(3) versus 1,25(OH)(2)D(3) Supplementation in Infantile Nephropathic Cystinosis-Associated Adipose Tissue Browning and Muscle Wasting
por: Zhou, Ping, et al.
Publicado: (2022)

Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation
por: Kavadichanda, Chengappa, et al.
Publicado: (2023)

Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study
por: McDonnell, Sharon L., et al.
Publicado: (2016)

Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort
por: McDonnell, Sharon L., et al.
Publicado: (2018)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

Both 25-Hydroxyvitamin-D(3) and 1,25-Dihydroxyvitamin-D(3) Reduces Inflammatory Response in Human Periodontal Ligament Cells
por: Andrukhov, Oleh, et al.
Publicado: (2014)

Vitamin D(3) and 25-Hydroxyvitamin D(3) Content of Retail White Fish and Eggs in Australia
por: Dunlop, Eleanor, et al.
Publicado: (2017)

Effects of 1,25(OH)(2)D(3) and 25(OH)D(3) on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy
por: van der Meijden, K., et al.
Publicado: (2016)

The genetic determinants of circulating C3-epimers of 25-hydroxyvitamin D
por: Torugsa, Sirikunya, et al.
Publicado: (2018)

Use of 25-hydroxyvitamin D(3) in diets for sows: A review
por: Zhang, Lianhua, et al.
Publicado: (2021)

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

Sunlight exposed body surface area is associated with serum 25-hydroxyvitamin D (25(OH)D) level in pregnant Minangkabau women, Indonesia
por: Ilmiawati, Cimi, et al.
Publicado: (2020)

The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency
por: Zielińska, Anna, et al.
Publicado: (2021)

Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Publicado: (2020)

25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
por: Jones, K. S., et al.
Publicado: (2014)

1,25-Dihydroxyvitamin D3 and 20-Hydroxyvitamin D3 Upregulate LAIR-1 and Attenuate Collagen Induced Arthritis
por: Myers, Linda K., et al.
Publicado: (2021)

Correction: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study
por: McDonnell, Sharon L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cif1jpis39p8cq7nv5mdkpse7o